CLASS II ANTIGENS AND DISEASE SUSCEPTIBILITY
- 1 February 1995
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 46 (1), 17-25
- https://doi.org/10.1146/annurev.med.46.1.17
Abstract
▪ Abstract The role for HLA typing in autoimmune disease is changing with the recognition that HLA markers can identify patients with poor prognosis in some autoimmune disease. Aggressive therapeutic intervention in patients with such HLA prognostic markers has the potential to improve or prevent progressive disease outcomes in a select group of patients.Keywords
This publication has 24 references indexed in Scilit:
- Selective immunosuppressionImmunology Today, 1993
- Strong association of insulin autoimmune syndrome with HLA-DR4The Lancet, 1992
- Prediction and prevention of IDDM--1991Diabetes, 1991
- Association of HLA–Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the “shared epitope” hypothesisArthritis & Rheumatism, 1991
- Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.The Journal of Experimental Medicine, 1990
- Mutagenesis and Expression of Putative Class II Susceptibility Genes: a “Reverse Immunogenetics” Approach to Analysis of HLA and DiseaseAutoimmunity, 1990
- Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mappingNature, 1989
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987
- Type I Diabetes MellitusNew England Journal of Medicine, 1986